It’s not either or
Thursday afternoon Dexcom will report earnings which should be just fine. As we witnessed with the results Abbott released nothing much has changed in the CGM world. Dexcom and Abbott dominate this market, will continue to do so for the foreseeable future and are unlikely to face any serious competition for at minimum 5 years likely longer. So why then is everyone trying to turn this into an either-or winner take all fight?
Here are the facts other than what we stated above
1. Dexcom has the G7 coming, Abbott Libre3 simply put the technology is getting better . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.